Resinib – 50 mg Capsule

859.66৳ 

Dosage : Capsule
Strength : 50 mg
Generic : Sunitinib
Pack Size : 1 Pack = 28’s
Manufacturer : Jenphar Bangladesh Ltd.

+
  • Resinib - 50 mg Capsule

    859.66৳ 

    Request a Call Back

    •  Size Guide

      Size Guide

    •  Delivery & Return

      Delivery

      Delivery Type

      Delivery Charge

      Delivery Time

      Free Delivery

      Free

      01 – 48 Hours

      Regular Delivery

      Tk. 25

      01 – 48 Hours

      Express Delivery

      Tk. 80

      01 – 03 Hours

      Store Pickup

      Free

      Currently, we deliver within 01 KM radius, Except as per the discussion

      Returns

      Return  FREE

      You can easily return your ordered medicine if :

      • Product Damaged
      • Expired
      • or Wrong Medicine

      found above issue please return to our delivery personnel during delivery time. After that we are unable to return your medicine.

    •  Ask a Question

      Resinib - 50 mg Capsule

      859.66৳ 

      Ask a Question

        ... people are viewing this right now

        Share
      Guaranteed Safe CheckoutTrust
      Recommended Dose For GIST And RCC:?The recommended dose of Sunitinib for gastrointestinal stromal tumor (GIST) and advanced?renal cell carcinoma?(RCC) is one 50 mg oral dose taken once daily, on a schedule of 4 weeks on treatment followed by 2 weeks off (Schedule 4/2). Sunitinib may be taken with or without food.

      Recommended Dose For pNET: The recommended dose of Sunitinib for pancreatic neuroendocrine tumors (pNET) is 37.5 mg taken orally once daily continuously without a scheduled off-treatment period. Sunitinib may be taken with or without food.

      Dose Modification: Dose interruption and/or dose modification in 12.5 mg increments or decrements is recommended based on individual safety and tolerability. The maximum dose administered in the Phase 3 pNET study was 50 mg daily.

      Strong CYP3A4 inhibitors such as ketoconazole may increas e sunitinib plasma concentrations. Selection of an alternate concomitant medication with no or minimal enzyme inhibition potential is recommended. A dose reduction for Sunitinib to a minimum of 37.5 mg (GIST and RCC) or 25 mg (pNET) daily should be considered if Sunitinib must be co-administered with a strong CYP3A4 inhibitor

      CYP3A4 inducers such as rifampin may decreas e sunitinib plasma concentrations. Selection of an alternate concomitant medication with no or minimal enzyme induction potential is recommended. A dose increase for Sunitinib to a maximum of 87.5 mg (GIST and RCC) or 62.5 mg (pNET) daily should be considered if Sunitinib must be co-administered with a CYP3A4 inducer. If dose is increased, the patient should be monitored carefully for toxicity

      Based on 0 reviews

      0.00 Overall
      0%
      0%
      0%
      0%
      0%
      Be the first to review “Resinib – 50 mg Capsule”

      Your email address will not be published. Required fields are marked *

      Write a review

      Reviews

      There are no reviews yet.

      SKU: 1501592 Category:  Tag: 
      My Cart
      Close Wishlist
      Close Recently Viewed
      Categories